Cambridge Investment Research Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,859
Closed -$310K 3076
2022
Q1
$310K Buy
1,859
+133
+8% +$25.3K ﹤0.01% 2520
2021
Q4
$308K Sell
1,726
-169
-9% -$30.2K ﹤0.01% 2506
2021
Q3
$335K Sell
1,895
-357
-16% -$59.2K ﹤0.01% 2372
2021
Q2
$362K Buy
2,252
+93
+4% +$14.3K ﹤0.01% 2326
2021
Q1
$323K Buy
+2,159
New +$262K ﹤0.01% 2229

Other funds holding CNXC

Cambridge Investment Research Advisors's CNXC Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of Concentrix (CNXC) in Q2 2022, closing a stake of 1,859 shares — an estimated $310K sold.

Cambridge Investment Research Advisors first reported a position in CNXC in Q1 2021 and held it in 5 quarters. The position peaked at $362K in Q2 2021. 325 funds tracked by Wall St. Rank hold CNXC as of Q2 2022.

  • Cambridge Investment Research Advisors reported no remaining Concentrix position as of Q2 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,859 Concentrix shares in Q2 2022, an estimated $310K.
  • Cambridge Investment Research Advisors first reported a position in Concentrix in Q1 2021 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's Concentrix position peaked at $362K in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Concentrix as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.